BiondVax Pharmaceuticals Ltd (NASDAQ:BVXV)

1.19
BATS BZX Real-Time Price
As of Jun 28
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
4.19
-49.36%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$22.2M

Company Description

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.

Contact Information

BiondVax Pharmaceuticals Ltd.
Jerusalem BioPark
Jerusalem Jerusalem 74036
P:9723029302529
Investor Relations:
9728

Employees

Shareholders

Other institutional1.41%
Mutual fund holders0.34%
Individual stakeholders--

Top Executives

Amir ReichmanChief Executive Officer & Director
Elad MarkChief Operating Officer
Uri Ben-OrChief Financial Officer
Tamar Ben-YedidiaChief Science Officer
Dalit Weinstein FischerHead-Technical, Research & Development